These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28910422)

  • 21. [Quantification of the curing effects of phenanthridine on yeast prion [PSI+]].
    Zhong Z; Wang L; Xie H; Li H; He J; Song Y
    Sheng Wu Gong Cheng Xue Bao; 2012 Jun; 28(6):737-46. PubMed ID: 23016310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI(+)] of Saccharomyces cerevisiae.
    Eaglestone SS; Ruddock LW; Cox BS; Tuite MF
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):240-4. PubMed ID: 10618402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wild yeast harbour a variety of distinct amyloid structures with strong prion-inducing capabilities.
    Westergard L; True HL
    Mol Microbiol; 2014 Apr; 92(1):183-93. PubMed ID: 24673812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicidal [PSI+] is a lethal yeast prion.
    McGlinchey RP; Kryndushkin D; Wickner RB
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5337-41. PubMed ID: 21402947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutants of the Paf1 complex alter phenotypic expression of the yeast prion [PSI+].
    Strawn LA; Lin CA; Tank EM; Osman MM; Simpson SA; True HL
    Mol Biol Cell; 2009 Apr; 20(8):2229-41. PubMed ID: 19225160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion Sup35p.
    Redeker V; Hughes C; Savistchenko J; Vissers JP; Melki R
    PLoS One; 2011; 6(9):e23659. PubMed ID: 21931608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PSI+]: an epigenetic modulator of translation termination efficiency.
    Serio TR; Lindquist SL
    Annu Rev Cell Dev Biol; 1999; 15():661-703. PubMed ID: 10611975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An engineered nonsense URA3 allele provides a versatile system to detect the presence, absence and appearance of the [PSI+] prion in Saccharomyces cerevisiae.
    Manogaran AL; Kirkland KT; Liebman SW
    Yeast; 2006 Jan; 23(2):141-7. PubMed ID: 16491470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication.
    Song Y; Wu YX; Jung G; Tutar Y; Eisenberg E; Greene LE; Masison DC
    Eukaryot Cell; 2005 Feb; 4(2):289-97. PubMed ID: 15701791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion-based memory of heat stress in yeast.
    Chernova TA; Chernoff YO; Wilkinson KD
    Prion; 2017 May; 11(3):151-161. PubMed ID: 28521568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chimeric yeast prions with unstable inheritance].
    Borkhsenius AS; Sasnauskas K; Gedvilaĭte A; Inge-Vechtomov SG
    Genetika; 2002 Mar; 38(3):300-5. PubMed ID: 11963556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ageing in yeast does not enhance prion generation.
    Shewmaker F; Wickner RB
    Yeast; 2006 Dec; 23(16):1123-8. PubMed ID: 17133618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    Mol Cell Biol; 1997 May; 17(5):2798-805. PubMed ID: 9111351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial sequestration and oligomer remodeling during de novo [PSI
    Lyke DR; Manogaran AL
    Prion; 2017 Sep; 11(5):332-337. PubMed ID: 28968144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antiprion effect of the anticytoskeletal drug latrunculin A in yeast.
    Bailleul-Winslett PA; Newnam GP; Wegrzyn RD; Chernoff YO
    Gene Expr; 2000; 9(3):145-56. PubMed ID: 11243411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sup35p yeast prion-like protein as an adapter for production of the Gag-p55 antigen of HIV-1 and the L-chain of botulinum neurotoxin in Saccharomyces cerevisiae.
    Ivanov PA; Lewitin EI; Shevelev BI; Fominov GV; Wojciechowska JA; Asadi Mobarhan AH; Vertie YV; Yankovsky NK; Shevelev AB
    Res Microbiol; 2001; 152(1):27-35. PubMed ID: 11281322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physical basis of how prion conformations determine strain phenotypes.
    Tanaka M; Collins SR; Toyama BH; Weissman JS
    Nature; 2006 Aug; 442(7102):585-9. PubMed ID: 16810177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 26S Proteasome Degrades the Soluble but Not the Fibrillar Form of the Yeast Prion Ure2p In Vitro.
    Wang K; Redeker V; Madiona K; Melki R; Kabani M
    PLoS One; 2015; 10(6):e0131789. PubMed ID: 26115123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.